55 related articles for article (PubMed ID: 22677171)
1. Alendronate promotes plasmin-mediated MMP-9 inactivation by exposing cryptic plasmin degradation sites within the MMP-9 catalytic domain.
Farina AR; Cappabianca L; Di Ianni N; Ruggeri P; Ragone M; Merolle S; Gulino A; Mackay AR
FEBS Lett; 2012 Jul; 586(16):2366-74. PubMed ID: 22677171
[TBL] [Abstract][Full Text] [Related]
2. Tissue inhibitor of metalloproteinase-2 protection of matrix metalloproteinase-2 from degradation by plasmin is reversed by divalent cation chelator EDTA and the bisphosphonate alendronate.
Farina AR; Tacconelli A; Teti A; Gulino A; Mackay AR
Cancer Res; 1998 Jul; 58(14):2957-60. PubMed ID: 9679953
[TBL] [Abstract][Full Text] [Related]
3. Plasmin activates pro-matrix metalloproteinase-2 with a membrane-type 1 matrix metalloproteinase-dependent mechanism.
Monea S; Lehti K; Keski-Oja J; Mignatti P
J Cell Physiol; 2002 Aug; 192(2):160-70. PubMed ID: 12115722
[TBL] [Abstract][Full Text] [Related]
4. Role of the fibrinolytic and matrix metalloproteinase systems in arterial neointima formation after vascular injury.
Lijnen HR
Verh K Acad Geneeskd Belg; 2001; 63(6):605-22. PubMed ID: 11813512
[TBL] [Abstract][Full Text] [Related]
5. uPA/plasmin system-mediated MMP-9 activation is implicated in bronchial epithelial cell migration.
Legrand C; Polette M; Tournier JM; de Bentzmann S; Huet E; Monteau M; Birembaut P
Exp Cell Res; 2001 Apr; 264(2):326-36. PubMed ID: 11262189
[TBL] [Abstract][Full Text] [Related]
6. Beta-hematin interaction with the hemopexin domain of gelatinase B/MMP-9 provokes autocatalytic processing of the propeptide, thereby priming activation by MMP-3.
Geurts N; Martens E; Van Aelst I; Proost P; Opdenakker G; Van den Steen PE
Biochemistry; 2008 Feb; 47(8):2689-99. PubMed ID: 18237197
[TBL] [Abstract][Full Text] [Related]
7. Regulation of gelatinase activity in mice with targeted inactivation of components of the plasminogen/plasmin system.
Lijnen HR; Silence J; Lemmens G; Frederix L; Collen D
Thromb Haemost; 1998 Jun; 79(6):1171-6. PubMed ID: 9657444
[TBL] [Abstract][Full Text] [Related]
8. Melatonin inhibits postischemic matrix metalloproteinase-9 (MMP-9) activation via dual modulation of plasminogen/plasmin system and endogenous MMP inhibitor in mice subjected to transient focal cerebral ischemia.
Tai SH; Chen HY; Lee EJ; Chen TY; Lin HW; Hung YC; Huang SY; Chen YH; Lee WT; Wu TS
J Pineal Res; 2010 Nov; 49(4):332-41. PubMed ID: 20663046
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of proteases involved in embryo implantation by cholesterol sulfate.
Koizumi M; Momoeda M; Hiroi H; Nakazawa F; Nakae H; Ohno T; Yano T; Taketani Y
Hum Reprod; 2010 Jan; 25(1):192-7. PubMed ID: 19897854
[TBL] [Abstract][Full Text] [Related]
10. Vascular smooth muscle cells efficiently activate a new proteinase cascade involving plasminogen and fibronectin.
Houard X; Monnot C; Dive V; Corvol P; Pagano M
J Cell Biochem; 2003 Apr; 88(6):1188-201. PubMed ID: 12647301
[TBL] [Abstract][Full Text] [Related]
11. Modulation of cell-associated plasminogen activation by stromelysin-1 (MMP-3).
Ugwu F; Lemmens G; Collen D; Lijnen HR
Thromb Haemost; 1999 Sep; 82(3):1127-31. PubMed ID: 10494776
[TBL] [Abstract][Full Text] [Related]
12. Plasmin induces degradation and dysfunction of laminin 332 (laminin 5) and impaired assembly of basement membrane at the dermal-epidermal junction.
Ogura Y; Matsunaga Y; Nishiyama T; Amano S
Br J Dermatol; 2008 Jul; 159(1):49-60. PubMed ID: 18460030
[TBL] [Abstract][Full Text] [Related]
13. Alendronate regulates cell invasion and MMP-2 secretion in human osteosarcoma cell lines.
Cheng YY; Huang L; Lee KM; Li K; Kumta SM
Pediatr Blood Cancer; 2004 May; 42(5):410-5. PubMed ID: 15049011
[TBL] [Abstract][Full Text] [Related]
14. Homophilic complex formation of MT1-MMP facilitates proMMP-2 activation on the cell surface and promotes tumor cell invasion.
Itoh Y; Takamura A; Ito N; Maru Y; Sato H; Suenaga N; Aoki T; Seiki M
EMBO J; 2001 Sep; 20(17):4782-93. PubMed ID: 11532942
[TBL] [Abstract][Full Text] [Related]
15. Generation of an angiostatin-like fragment from plasminogen by stromelysin-1 (MMP-3).
Lijnen HR; Ugwu F; Bini A; Collen D
Biochemistry; 1998 Apr; 37(14):4699-702. PubMed ID: 9548733
[TBL] [Abstract][Full Text] [Related]
16. Novel laminin 5 gamma 2-chain fragments potentiating the limbal epithelial cell outgrowth on amniotic membrane.
Cheng CY; Sun CC; Yu WH; Hsieh HL; Ma DH; Pang JH; Yang CM
Invest Ophthalmol Vis Sci; 2009 Oct; 50(10):4631-9. PubMed ID: 19420329
[TBL] [Abstract][Full Text] [Related]
17. Independent regulation of matrix metalloproteinases and plasminogen activators in human fibrosarcoma cells.
Lim YT; Sugiura Y; Laug WE; Sun B; Garcia A; DeClerck YA
J Cell Physiol; 1996 May; 167(2):333-40. PubMed ID: 8613475
[TBL] [Abstract][Full Text] [Related]
18. Significance of coexpression of urokinase-type plasminogen activator, and matrix metalloproteinase 3 (stromelysin) and 9 (gelatinase B) in colorectal carcinoma.
Inuzuka K; Ogata Y; Nagase H; Shirouzu K
J Surg Res; 2000 Oct; 93(2):211-8. PubMed ID: 11027463
[TBL] [Abstract][Full Text] [Related]
19. Enzymatic modification of low-density lipoprotein in the arterial wall: a new role for plasmin and matrix metalloproteinases in atherogenesis.
Torzewski M; Suriyaphol P; Paprotka K; Spath L; Ochsenhirt V; Schmitt A; Han SR; Husmann M; Gerl VB; Bhakdi S; Lackner KJ
Arterioscler Thromb Vasc Biol; 2004 Nov; 24(11):2130-6. PubMed ID: 15345515
[TBL] [Abstract][Full Text] [Related]
20. Apolactoferrin inhibits the catalytic domain of matrix metalloproteinase-2 by zinc chelation.
Newsome AL; Johnson JP; Seipelt RL; Thompson MW
Biochem Cell Biol; 2007 Oct; 85(5):563-72. PubMed ID: 17901898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
